Laxminarayan, Ramanan

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 6,142

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015

Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 3,232

Access to effective antimicrobials: a worldwide challenge

Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 1,465

Global trends in antimicrobial resistance in animals in low- and middle-income countries

Van Boeckel, T. P., Pires, J., Silvester, R., Zhao, C., Song, J., Criscuolo, N. G., Gilbert, M., Bonhoeffer, S., & Laxminarayan, R. (2019) · Science

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 1,160

The global threat of antimicrobial resistance: science for intervention.

Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 1,106

Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition

Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., Ferrari, A. J., Hyman, S., Laxminarayan, R., Levin, C., et al. (2016) · The Lancet

Mental Health Treatment and AccessHealth Systems, Economic Evaluations, Quality of Life

Cited by 889

Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data

Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R. (2021) · The Lancet Infectious Diseases

Antibiotic Use and ResistanceAntibiotic Resistance in Bacteria

Cited by 500

Epidemiology and transmission dynamics of COVID-19 in two Indian states

Laxminarayan, R., Wahl, B., Dudala, S. R., Gopal, K., Mohan B, C., Neelima, S., Jawahar Reddy, K. S., Radhakrishnan, J., & Lewnard, J. A. (2020) · Science

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 485

Investment in child and adolescent health and development: key messages from Disease Control Priorities , 3rd Edition

Bundy, D. A. P., de Silva, N., Horton, S., Patton, G. C., Schultz, L., Jamison, D. T., Abubakara, A., Ahuja, A., Alderman, H., Allen, N., et al. (2018) · The Lancet

Child Nutrition and Water AccessGlobal Maternal and Child Health

Cited by 253

Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition

Jamison, D. T., Alwan, A., Mock, C. N., Nugent, R., Watkins, D., Adeyi, O., Anand, S., Atun, R., Bertozzi, S., Bhutta, Z., et al. (2018) · The Lancet

Healthcare Systems and ReformsHealthcare Systems and Practices

Cited by 227

Antibiotic effectiveness: Balancing conservation against innovation

Laxminarayan, R. (2014) · Science

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 170

Disease Control Priorities, Third Edition (Volume 4): Mental, Neurological, and Substance Use Disorders

Patel, V., Chisholm, D., Dua, T., Laxminarayan, R., & Medina-Mora, M. E. (2016) · World Bank, Washington, DC eBooks

Mental Health Treatment and AccessHealth Systems, Economic Evaluations, Quality of Life

Cited by 130

Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance

Laxminarayan, R., Impalli, I., Rangarajan, R., Cohn, J., Ramjeet, K., Trainor, B. W., Strathdee, S., Sumpradit, N., Berman, D., Wertheim, H., et al. (2024) · The Lancet

Antibiotic Use and ResistancePharmaceutical Economics and Policy

Cited by 111

Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006

Klein, E. Y., Smith, D. L., & Laxminarayan, R. (2009) · Emerging Infectious Diseases

Antimicrobial Resistance in StaphylococcusAntibiotic Use and Resistance

Cited by 102

Global trends in inappropriate use of antibiotics, 2000–2021: scoping review and prevalence estimates

Mulchandani, R., Tiseo, K., Nandi, A., Klein, E., Gandra, S., Laxminarayan, R., & Van Boeckel, T. (2025) · BMJ Public Health

Antibiotic Use and ResistancePharmaceutical Practices and Patient Outcomes

Cited by 68

SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study

Laxminarayan, R., B, C. M., G, V. T., Arjun Kumar, K. V., Wahl, B., & Lewnard, J. A. (2021) · The Lancet Infectious Diseases

COVID-19 Clinical Research StudiesCOVID-19 epidemiological studies

Cited by 43

Attributed causes of excess mortality during the COVID-19 pandemic in a south Indian city

Lewnard, J. A., B, C. M., Kang, G., & Laxminarayan, R. (2023) · Nature Communications

COVID-19 epidemiological studiesCOVID-19 and healthcare impacts

Cited by 23

Food Coma is Real: The Effect of Digestive Fatigue on Adolescents' Cognitive Performance

Hervé, J., Mani, S., Behrman, J. R., Laxminarayan, R., & Nandi, A. (2024) · Social Science Research Network

Sleep and Work-Related FatigueEducational Outcomes and Influences

Cited by 0